Deniz Avcı

421 citations
36 papers · 290 indexed · h-index 12

Deniz Avcı

31 papers receiving 282 citations

Peers

Deniz Avcı
Comparison fields: 5 of 69
  • Sensory Systems 24
  • Pharmacology 35
  • Obstetrics and Gynecology 21
  • Nephrology 19
  • Emergency Medicine 23
Replace Peng Ding with:
Peng Ding China
Jing Zeng China
J Prinseau France
Cengiz Pata Türkiye
Satoshi Tatemichi Japan
Jessica Seeßle Germany
Alexandru Doşa Romania
Gregory K Pike Australia
Elena Tortorici Italy
Heinfried Schmidt Germany
Deniz Avcı relative to Peng Ding China Peng Ding's profile →
Citations per field
00.5×
Peng Ding · 1×
Citations per year

Countries citing papers authored by Deniz Avcı

Since Specialization
Citations

This map shows the geographic impact of Deniz Avcı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deniz Avcı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deniz Avcı more than expected).

Fields of papers citing papers by Deniz Avcı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deniz Avcı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deniz Avcı. The network helps show where Deniz Avcı may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Deniz Avcı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deniz Avcı Line = papers co-authored together Deniz Avcı links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20211
3 20218
4 20211
5 20202
6 20181
7 20188
8
Which one is best? platelet/lymphocyte ratio, neutrophil/lymphocyte ratio or both in determining deep venous thrombosis in behcet' s disease?
20177
9 201725
10 20160
11 201610
12 20164
13 201613
14 20161
15 201516
16 201412
17 201413
18 20130
19 201317
20 201311

About Deniz Avcı

Deniz Avcı is a scholar working on Internal Medicine, Otorhinolaryngology and Ophthalmology, having authored 36 papers that have together received 290 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Hearing, Cochlea, Tinnitus, Genetics (3 papers), Poisoning and overdose treatments (3 papers), Vestibular and auditory disorders (3 papers), Autoimmune Bullous Skin Diseases (2 papers) and Musculoskeletal synovial abnormalities and treatments (2 papers). The work is most often cited by research in Sensory Systems (24 citations), Pharmacology (35 citations) and Obstetrics and Gynecology (21 citations). Deniz Avcı has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Mustafa Başak, Abdülsamet Erden, Orhan Kürşat Poyrazoğlu, İ̇lhami Çelik, Kemal Özyurt, Çiğdem Karakükçü, Derya Koçer, Kürşat Gündoğan, Oğuzhan Sıtkı Dizdar and Mustafa Atasoy. Their work appears in journals such as SHILAP Revista de lepidopterología, Nutrients and International Journal of Radiation Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026